Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02832115
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Aultman Health Foundation
- Registry
-
NCT02832115
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02832115. Randomized; double masking; primary purpose prevention. Start 2016-09 (actual); primary completion 2019-05-02 (actual). Results posted on 2020-10-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
- Acronym
- TNT-RASP
- Condition
- Radial Artery Spasm
- Condition
- Angina
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Topical Nitroglycerine
- Intervention (Drug)
- Topical Lidocaine
- Lead sponsor
- Aultman Health Foundation
Record details
- Record id
cardio:ct-nct02832115- Content hash
785c5ece5d32e0618223c2039bbba188a91202bb7260b6b3ed76e6d5a07657b2